Stock Activity: Versartis (NASDAQ:VSAR), Advaxis (NASDAQ:ADXS), Asterias Biotherapeutics (NYSEMKT:AST), Gilat Satellite Networks (NASDAQ:GILT)

Streamline Health Solutions, Inc. (NASDAQ:STRM) shares fell -2.91% in last trading session and ended the day at $1.67. STRM Gross Margin is 56.70% and its has a return on assets of -19.80%. Streamline Health Solutions, Inc. (NASDAQ:STRM) quarterly performance is -41.61%.

Levi & Korsinsky announces it has commenced an investigation of Streamline Health Solutions, Inc. (NASDAQ:STRM) concerning possible breaches of fiduciary duty by the board of directors of the company.

Versartis, Inc. (NASDAQ:VSAR) ended the last trading day at $10.42. Company weekly volatility is calculated as 6.44% and price to cash ratio as 1.55. Versartis, Inc. (NASDAQ:VSAR) showed a weekly performance of 5.57%.

Versartis, Inc. (NASDAQ:VSAR), announced that Mr. Jay Shepard, President and Chief Executive Officer, presented at the Credit Suisse 24th Annual Healthcare Conference on Tuesday, November 10 in Scottsdale, Arizona.

On 19 November, Advaxis, Inc. (NASDAQ:ADXS) shares fell -3.63% and was closed at $11.41. ADXS EPS growth in last 5 year was -24.50%. Advaxis, Inc. (NASDAQ:ADXS) year to date (YTD) performance is 42.45%.

On 9 November, Advaxis, Inc. (NASDAQ:ADXS), presented a poster featuring clinical development advances with its Lm Technology™ at the Society for Immunotherapy of Cancer 2015 Annual Meeting in National Harbor, Md. The purpose of this study was to evaluate whether axalimogene filolisbac could be dosed at higher levels than previous studies conducted by Advaxis in patients with persistent or recurrent metastatic (squamous or non-squamous cell) carcinoma of the cervix (PRmCC).

Asterias Biotherapeutics, Inc. (NYSEMKT:AST) shares advanced 3.73% in last trading session and ended the day at $5.00. AST Gross Margin is 92.50% and its has a return on assets of -25.40%. Asterias Biotherapeutics, Inc. (NYSEMKT:AST) quarterly performance is 36.24%.

Levi & Korsinsky announces it has commenced an investigation of Asterias Biotherapeutics, Inc. (NYSE MKT: AST) concerning possible breaches of fiduciary duty by its Board of Directors.

Gilat Satellite Networks Ltd. (NASDAQ:GILT) caters to the Technology space. It has a net profit margin of -5.60% and weekly performance is 1.49%. On the last day of trading company shares ended up at $3.41. Gilat Satellite Networks Ltd. (NASDAQ:GILT) distance from 50-day simple moving average (SMA50) is 2.77%.

Gilat Satellite Networks Ltd. (NASDAQ:GILT) operating loss was $5.8 million in the third quarter of 2015, compared to an operating income of $3.6 million in the comparable quarter of 2014. On a GAAP basis, operating loss, including impairment of goodwill and restructuring costs, was $29.1 million in the third quarter of 2015, compared to an operating income of $1.5 million in the comparable quarter of 2014. On a non-GAAP basis, net loss for the quarter was $8.9 million or $0.20 per diluted share, compared to net income of $3.0 million or $0.07 per diluted share in the same quarter of 2014.

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *